These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 15138588)

  • 1. Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomas.
    Hamano S; Ohira M; Isogai E; Nakada K; Nakagawara A
    Int J Oncol; 2004 Jun; 24(6):1457-66. PubMed ID: 15138588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of proapoptotic BMCC1, a novel gene with the BNIP2 and Cdc42GAP homology (BCH) domain, is associated with favorable prognosis in human neuroblastomas.
    Machida T; Fujita T; Ooo ML; Ohira M; Isogai E; Mihara M; Hirato J; Tomotsune D; Hirata T; Fujimori M; Adachi W; Nakagawara A
    Oncogene; 2006 Mar; 25(13):1931-42. PubMed ID: 16288218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma.
    Islam A; Kageyama H; Takada N; Kawamoto T; Takayasu H; Isogai E; Ohira M; Hashizume K; Kobayashi H; Kaneko Y; Nakagawara A
    Oncogene; 2000 Feb; 19(5):617-23. PubMed ID: 10698506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of the candidate tumor suppressor gene ING1 is associated with poor prognosis in advanced neuroblastomas.
    Takahashi M; Ozaki T; Todo S; Nakagawara A
    Oncol Rep; 2004 Oct; 12(4):811-6. PubMed ID: 15375504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
    Nakagawara A; Arima-Nakagawara M; Scavarda NJ; Azar CG; Cantor AB; Brodeur GM
    N Engl J Med; 1993 Mar; 328(12):847-54. PubMed ID: 8441429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma.
    Eggert A; Ikegaki N; Liu XG; Brodeur GM
    Klin Padiatr; 2000; 212(4):200-5. PubMed ID: 10994551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of pleiotrophin and midkine in advanced neuroblastomas.
    Nakagawara A; Milbrandt J; Muramatsu T; Deuel TF; Zhao H; Cnaan A; Brodeur GM
    Cancer Res; 1995 Apr; 55(8):1792-7. PubMed ID: 7712489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-MYC promotes cell proliferation through a direct transactivation of neuronal leucine-rich repeat protein-1 (NLRR1) gene in neuroblastoma.
    Hossain MS; Ozaki T; Wang H; Nakagawa A; Takenobu H; Ohira M; Kamijo T; Nakagawara A
    Oncogene; 2008 Oct; 27(46):6075-82. PubMed ID: 18591937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer.
    Zhang Y; Dang C; Ma Q; Shimahara Y
    Oncol Rep; 2005 Jul; 14(1):161-71. PubMed ID: 15944784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells.
    Spengler BA; Lazarova DL; Ross RA; Biedler JL
    Oncol Res; 1997; 9(9):467-76. PubMed ID: 9495452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
    Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
    Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association among EPHB2, TrkA, and MYCN expression in low-stage neuroblastomas.
    Tang XX; Evans AE; Zhao H; Cnaan A; Brodeur GM; Ikegaki N
    Med Pediatr Oncol; 2001 Jan; 36(1):80-2. PubMed ID: 11464911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuron-specific hel-N1 and HuD as novel molecular markers of neuroblastoma: a correlation of HuD messenger RNA levels with favorable prognostic features.
    Ball NS; King PH
    Clin Cancer Res; 1997 Oct; 3(10):1859-65. PubMed ID: 9815574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification.
    Raschellà G; Cesi V; Amendola R; Negroni A; Tanno B; Altavista P; Tonini GP; De Bernardi B; Calabretta B
    Cancer Res; 1999 Jul; 59(14):3365-8. PubMed ID: 10416595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genes induced in programmed cell death of neuronal PC12 cells and developing sympathetic neurons in vivo.
    Wang S; Dibenedetto AJ; Pittman RN
    Dev Biol; 1997 Aug; 188(2):322-36. PubMed ID: 9268578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cotransfection of TrkA and p75(NTR) in neuroblastoma cell line (IMR-32) promotes differentiation and apoptosis of tumor cells.
    Chen J; Zhe X
    Chin Med J (Engl); 2003 Jun; 116(6):906-12. PubMed ID: 12877805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of NLRR3 orphan receptor gene is negatively regulated by MYCN and Miz-1, and its downregulation is associated with unfavorable outcome in neuroblastoma.
    Akter J; Takatori A; Hossain MS; Ozaki T; Nakazawa A; Ohira M; Suenaga Y; Nakagawara A
    Clin Cancer Res; 2011 Nov; 17(21):6681-92. PubMed ID: 21908575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas.
    Tang XX; Evans AE; Zhao H; Cnaan A; London W; Cohn SL; Brodeur GM; Ikegaki N
    Clin Cancer Res; 1999 Jun; 5(6):1491-6. PubMed ID: 10389937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of the novel endothelin-converting enzyme genes, Nbla03145/ECEL1alpha and beta, is associated with favorable prognosis in human neuroblastomas.
    Kawamoto T; Ohira M; Hamano S; Hori T; Nakagawara A
    Int J Oncol; 2003 Apr; 22(4):815-22. PubMed ID: 12632073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The calcium-sensing receptor and parathyroid hormone-related protein are expressed in differentiated, favorable neuroblastic tumors.
    de Torres C; Beleta H; Díaz R; Toran N; Rodríguez E; Lavarino C; García I; Acosta S; Suñol M; Mora J
    Cancer; 2009 Jun; 115(12):2792-803. PubMed ID: 19350667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.